Cost-effectiveness of oral agents in relapsing-remitting multiple sclerosis compared to interferon-based therapy in Saudi Arabia

por Alsaqa’aby, Mai F., Vaidya, Varun, Khreis, Noura, Al Khairallah, Thamer, Al-jedai, Ahmed H.
Publicado 2017